Dogwood Therapeutics, Inc. (DWTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $42.43M
Last updated: Nov 17, 2026 at 11:01 AM ET
Dogwood Therapeutics, Inc. (DWTX) Stock Forecast
Analysts expect Dogwood Therapeutics (DWTX) to earn -$0.78 per share in the fiscal year ending Dec 31, 2026, on revenue of $100000. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.63.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$0.78
- EPS consensus, revenue $100000
- Fiscal year ending Dec 31, 2027
- -$0.63
- EPS consensus
- Next report
- Mar 16, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.78 | -$0.78 to -$0.78 | 1 | $100000 | $100000 to $100000 | 1 |
| Dec 31, 2027 | -$0.63 | -$0.78 to -$0.47 | 3 | N/A | N/A | 3 |
Quarterly Estimates
The EPS consensus is -$0.16 for both quarters below, ending Dec 31, 2026 and Mar 31, 2027.
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.16 | N/A | 4 |
| Mar 31, 2027 | -$0.16 | -$0.16 to -$0.16 | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 1 upward and 4 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 2 |
| Fiscal year ending Dec 31, 2027 | 1 | 1 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.59.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.78 | -$0.88 | -$0.88 | -$0.88 | -$0.59 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.63 | -$0.64 | -$0.64 | -$0.64 | -$0.65 | N/A |
| Quarter ending Mar 31, 2027 | -$0.16 | -$0.16 | -$0.16 | -$0.16 | -$0.15 | N/A |
Frequently Asked Questions About DWTX
What is the DWTX stock forecast?
Consensus analyst estimates put Dogwood Therapeutics's EPS at -$0.78 for the fiscal year ending Dec 31, 2026, on revenue of $100000.
What EPS do analysts expect from DWTX next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.78, with estimates from -$0.78 to -$0.78 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.63, with estimates from -$0.78 to -$0.47 from 3 analysts.
What revenue do analysts expect from Dogwood Therapeutics next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $100000, with estimates from $100000 to $100000.
How many analysts cover DWTX?
1 analyst estimates EPS for Dogwood Therapeutics for the fiscal year ending Dec 31, 2026.
DWTX pages: Overview, Earnings, Forecast, Financials, Competitors